Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andres Schrader
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients With Castration Resistant Prostate Cancer
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Related publications
Remarkable Response to Abiraterone Acetate in Castration-Resistant Prostate Cancer Patient With Aggressive Liver Metastasis
IJU Case Reports
The First Experience in Using Abiraterone Acetate in Patients With Castration-Refractory Prostate Cancer
Andrologia i Genital'naa Hirurgia
Surgery
Reproductive Medicine
Urology
Dynamic Changes of Alkaline Phosphatase Are Strongly Associated With PSA-decline and Predict Best Clinical Benefit Earlier Than PSA-changes Under Therapy With Abiraterone Acetate in Bone Metastatic Castration Resistant Prostate Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Predictors of Long-Term Response to Abiraterone in Patients With Metastastic Castration-Resistant Prostate Cancer: A Retrospective Cohort Study
Oncotarget
Oncology
Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer
Journal of Urology
Urology
Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer
European Urology
Urology
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate
Canadian Urological Association Journal
Urology
A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer
Cancer
Cancer Research
Oncology